Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Agata Michalak
Observed name:
Michalak, Agata
Institution:
Medical University of Lublin
Observed institution:
Medical University of Lublin
ORCID:
0000-0003-4426-6321
Observed ORCID:
0000-0003-4426-6321
OpenAlex ID:
A5070532933
Autoimmunity, New Potential Biomarkers and the Thyroid Gland—The Perspective of Hashimoto’s Thyroiditis and Its Treatment
2024
·
Ewa Tywanek
, Agata Michalak
, et al.
·
International Journal of Molecular Sciences
·
115
PDF
Liver injury in the era of COVID-19
2021
·
Halina Cichoż-Lach
, Agata Michalak
·
World Journal of Gastroenterology
·
107
Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy
2013
·
Halina Cichoż-Lach
, Agata Michalak
·
World Journal of Gastroenterology
·
91
PDF
Oxidative Stress—A Key Player in the Course of Alcohol-Related Liver Disease
2021
·
Agata Michalak
, Tomasz Lach
, et al.
·
Journal of Clinical Medicine
·
58
PDF
A Comprehensive Review of Bioelectrical Impedance Analysis and Other Methods in the Assessment of Nutritional Status in Patients with Liver Cirrhosis
2017
·
Halina Cichoż-Lach
, Agata Michalak
·
Gastroenterology Research and Practice
·
40
PDF
Red blood cell distribution width derivatives in alcohol-related liver cirrhosis and metabolic-associated fatty liver disease
2022
·
Agata Michalak
, Małgorzata Guz
, et al.
·
World Journal of Gastroenterology
·
34
Impact of Obesity on the Course of Management of Inflammatory Bowel Disease—A Review
2022
·
Agata Michalak
, Beata Kasztelan-Szczerbińska
, et al.
·
Nutrients
·
33
PDF
Plateletcrit and Mean Platelet Volume in the Evaluation of Alcoholic Liver Cirrhosis and Nonalcoholic Fatty Liver Disease Patients
2021
·
Agata Michalak
, Halina Cichoż-Lach
, et al.
·
BioMed Research International
·
33
PDF
The Usefulness of Extended Inflammation Parameters and Systemic Inflammatory Response Markers in the Diagnostics of Autoimmune Hepatitis
2022
·
Weronika Domerecka
, Anna Kowalska-Kępczyńska
, et al.
·
Cells
·
27
PDF
Indicator of Inflammation and NETosis—Low-Density Granulocytes as a Biomarker of Autoimmune Hepatitis
2022
·
Weronika Domerecka
, Iwona Homa-Mlak
, et al.
·
Journal of Clinical Medicine
·
22
PDF
Etiopathogenesis and Diagnostic Strategies in Autoimmune Hepatitis
2021
·
Weronika Domerecka
, Anna Kowalska-Kępczyńska
, et al.
·
Diagnostics
·
19
PDF
Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales
2020
·
Agata Michalak
, Halina Cichoż-Lach
, et al.
·
World Journal of Gastroenterology
·
19
Deviations in Peripheral Blood Cell Populations are Associated with the Stage of Primary Biliary Cholangitis and Presence of Itching
2018
·
Halina Cichoż-Lach
, Ewelina Grywalska
, et al.
·
Archivum Immunologiae et Therapiae Experimentalis
·
18
PDF
A rare case of skin blistering and esophageal stenosis in the course of epidermolysis bullosa - case report and literature review
2018
·
Agata Michalak
, Halina Cichoż-Lach
, et al.
·
BMC Gastroenterology
·
11
PDF
Gender-related disparities in the frequencies of PD-1 and PD-L1 positive peripheral blood T and B lymphocytes in patients with alcohol-related liver disease: a single center pilot study
2021
·
Beata Kasztelan-Szczerbinska
, Katarzyna Adamczyk
, et al.
·
PeerJ
·
10
Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study)
2021
·
Halina Cichoż-Lach
, Agata Michalak
, et al.
·
Therapeutic Advances in Gastroenterology
·
10
PDF
Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study
2023
·
Piotr Eder
, Maria Kłopocka
, et al.
·
Therapeutic Advances in Gastroenterology
·
9
Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn’s disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II)
2024
·
Ariel Liebert
, Maria Kłopocka
, et al.
·
Therapeutic Advances in Gastroenterology
·
8
COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?
2024
·
Agata Michalak
, Tomasz Lach
, et al.
·
International Journal of Molecular Sciences
·
5
PDF
Tuberculosis of tongue in patient with disseminated pulmonary tuberculosis
2008
·
Agata Michalak
, Grzegorz Wojtas
, et al.
·
Pneumonologia i Alergologia Polska
·
4
PDF
miRNAs and Hematological Markers in Non-Alcoholic Fatty Liver Disease—A New Diagnostic Path?
2025
·
Agata Michalak
, Małgorzata Guz
, et al.
·
Biomedicines
·
3
PDF
Pruritus in liver disease – pathenogenisis and treatment
2011
·
Agata Michalak
, Magdalena Hanc
, et al.
·
Journal of Pre-Clinical and Clinical Research
·
3
Multicentre retrospective real-world evidence study evaluating the effectiveness and safety of mirikizumab in patients with moderately to severely active ulcerative colitis
2026
·
Łukasz Lamparski
, Katarzyna Karłowicz
, et al.
·
Gastroenterology Review
·
2
PDF
microRNAs and Other Serological Markers of Liver Fibrosis in Patients with Alcohol-Related Liver Cirrhosis
2024
·
Agata Michalak
, Małgorzata Guz
, et al.
·
Biomedicines
·
2
PDF
COVID-19 z perspektywy szpitala klinicznego
2020
·
Szczepan Cofta
, Agata Michalak
·
Menedżer Zdrowia
·
2
Show more works
View as search
Works count:
38
Citation count:
693
H-index:
13
I10-index:
16
Year
Topic
Type